Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Zoloft (sertraline) has interactions with many types of medications, including other antidepressants, amphetamines, blood ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Explore new findings on bipolar disorder, from genetics to sleep patterns, plus emerging treatments and a neuroscientist’s ...